Table 3.
HR | (95% CI) | |
---|---|---|
Crude Time to all-cause death | 2.50 | (1.59, 3.93) |
Crude Time to cancer-specific death: | 2.19 | (1.36, 3.53) |
Adjusted for: Stage^ | 2.45 | (1.51, 3.96) |
Stage, SEIFA^^ | 2.41 | (1.47, 3.93) |
Stage, SEIFA, CCI score # | 2.35 | (1.42, 3.78) |
Stage, SEIFA, diabetes | 2.34 | (1.42, 3.85) |
Stage, SEIFA, CCI score, any treatment | 1.88 | (1.10, 3.22) |
Stage, SEIFA, CCI score, curative treatment | 1.59 | (0.92, 2.73) |
Stage, SEIFA, CCI score, mode of treatment## | 1.50 | (0.86, 2.64) |
Crude Time to non-cancer death | 7.33 | (1.52, 35.1) |
Adjusted for: any treatment | 5.83 | (1.09, 31.04) |
^ Stage: 1 = localised, 2 = regional spread, 3 = distant metastasis, 4 = not known
^^ SEIFA: 1 = Most disadvantaged, 2 = Mod disadvantage, 3 = Most Advantaged
# Charlson Comorbidity Index (CCI) score: 1 = 0, 2 = 1, 3 = 2-5, 4 = 5+
## Modes of treatment: 0 = No Treatment 1 = surgery, 2 = chemotherapy only, 3 = radiotherapy only, 4 = surgery and radiotherapy, 5 = surgery, chemotherapy and radiotherapy, 6 = chemoradiation